The incidence of AEs was markedly lower with canagliflozin (RR = 0.83, 95% CrI: 0.70, 0.97), empagliflozin (RR = 0.85, 95% CrI: 0.71, 0.99), linagliptin (RR = 0.85, 95% CrI: 0.71, 1.00), and vildagliptin (RR = 0.82, 95% CrI: 0.66, 0.99) than with cotadutide
Considering these time-course study results, the vehicle treatment group showed increased energy expenditure just before and after the light and dark cycles, indicating that these time points were feeding times
In obese patients, acipimox can inhibit adipose tissue lipolysis by activating protein upregulated in macrophage by INF- (PUMA-G) (also known as the hydroxycarboxylic acid receptor 2 [HCA2] and GPR109a) receptors
Specificity and sensitivity of commercially available assays for glucagon-like peptide 1 (GLP-1): implications for GLP-1 measurements in clinical studies